| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.054 | 0.8 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.05 | 0.8 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |